131 related articles for article (PubMed ID: 23315266)
1. Modification of proportion sensitivity testing method for ethionamide.
Lakshmi R; Ramachandran R; Devika K; Radhika G; Syam Sundar A; Rahman F; Selvakumar N; Kumar V
World J Microbiol Biotechnol; 2013 Jun; 29(6):1117-9. PubMed ID: 23315266
[TBL] [Abstract][Full Text] [Related]
2. Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide.
Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
J Antimicrob Chemother; 2004 Apr; 53(4):600-3. PubMed ID: 14973155
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the susceptibility testing of Mycobacterium tuberculosis to ethionamide in solid culture medium.
Lakshmi R; Ramachandran R; Kumar DR; Sundar AS; Radhika G; Rahman F; Selvakumar N; Kumar V
Indian J Med Res; 2015 Nov; 142(5):538-42. PubMed ID: 26658587
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
Şimşek H; Tarhan G; Cesur S
Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
[TBL] [Abstract][Full Text] [Related]
5. Consistency of standard laboratory strain Mycobacterium tuberculosis H 37 Rv with ethionamide susceptibility testing.
Lakshmi R; Kumar V; Rahman F; Ramachandran R
Indian J Med Res; 2012 May; 135(5):672-4. PubMed ID: 22771598
[TBL] [Abstract][Full Text] [Related]
6. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis].
Rueda J; Realpe T; Mejía G; Zapata E; Robledo J
Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443
[TBL] [Abstract][Full Text] [Related]
7. Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.
Lin SY; Desmond E; Bonato D; Gross W; Siddiqi S
J Clin Microbiol; 2009 Nov; 47(11):3630-4. PubMed ID: 19741086
[TBL] [Abstract][Full Text] [Related]
8. Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar.
Satana D; Coban AY; Uzun M
J Clin Microbiol; 2010 Nov; 48(11):4291-3. PubMed ID: 20826642
[TBL] [Abstract][Full Text] [Related]
9. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
10. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.
Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M
J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241
[TBL] [Abstract][Full Text] [Related]
11. Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of
de Welzen L; Eldholm V; Maharaj K; Manson AL; Earl AM; Pym AS
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993337
[TBL] [Abstract][Full Text] [Related]
12. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
[TBL] [Abstract][Full Text] [Related]
13. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
Nonghanphithak D; Kaewprasert O; Chaiyachat P; Reechaipichitkul W; Chaiprasert A; Faksri K
PLoS One; 2020; 15(12):e0244829. PubMed ID: 33382836
[TBL] [Abstract][Full Text] [Related]
14. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
[TBL] [Abstract][Full Text] [Related]
15. [Cross-resistance between isoniazid and ethionamide and its strong association with mutation C-15T in Mycobacterium tuberculosis isolates from Peru].
Sandoval R; Monteghirfo M; Salazar O; Galarza M
Rev Argent Microbiol; 2020; 52(1):36-42. PubMed ID: 31255368
[TBL] [Abstract][Full Text] [Related]
16. Standardization of first and second-line antitubercular susceptibility testing using BacT Alert 3D system: a report from a tertiary care centre in India.
Nair D; Capoor MR; Rawat D; Srivastava L; Aggarwal P
Braz J Infect Dis; 2009 Dec; 13(6):422-6. PubMed ID: 20464333
[TBL] [Abstract][Full Text] [Related]
17. Rapid detection of
Iftikhar I; Irfan S; Farooqi J; Azizullah Z; Hasan R
Int J Mycobacteriol; 2017; 6(2):117-121. PubMed ID: 28559510
[TBL] [Abstract][Full Text] [Related]
18. Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis.
Hicks ND; Carey AF; Yang J; Zhao Y; Fortune SM
mBio; 2019 Apr; 10(2):. PubMed ID: 31015328
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
[TBL] [Abstract][Full Text] [Related]
20. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
